| Risk Factors
Dupuytrens contracture is a thickening and shortening of the fascia in the palm of the hand. The fascia is a firm tissue that lies just below the skin. This condition causes affected fingers to curl towards the palm and makes extension of these fingers difficult or impossible.
Dupuytren's Contracture Scarring
Copyright © Nucleus Medical Media, Inc.
The exact cause of Dupuytrens contracture is unknown. For some people, the condition is inherited.
This condition is more common in men and those over 40 years of age.
Factors that may increase your chances of getting Dupuytrens contracture include:
- A parent with Dupuytrens contracture
- Hand trauma
- Manual labor
- Vibration exposure at work
- Alcohol abuse
- Use of certain anticonvulsant medications for epilepsy
- Liver disease
At first, symptoms of finger curling are mild, but they may worsen over time. The rate of progression varies among people.
The ring finger is usually affected first, followed by the little finger, then the index, and long finger. Fingers on either or both hands can be affected. The first physical sign of this condition is a nodule in the palm near the base of a finger. A nodule is a small thickening of the fascia under the skin. In some cases, nodules can be sensitive to touch. Generally, though, this condition is not painful.
As a contracture progresses, the nodule becomes a thickened fibrous cord that extends into the finger under the skin. As the cord thickens and shortens, the affected finger is pulled (curled) in towards the palm. It becomes difficult or impossible to extend the finger.
You will be asked about your symptoms and medical history. A hand examination will be done.
Images may be taken of your hand. This can be done with:
No treatment is necessary when symptoms are mild and do not effect normal use of the hand. In other cases, treatment may include:
Surgery is most effective when the condition is still in the nodule stage.
Depending on how far the condition has progressed, surgery may involve:
- Making small incisions in the thickened tissue
- Removing diseased tissue
- Removing diseased tissue and overlying damaged skin, and then repairing resulting gaps in skin with skin grafts
- Percutaneous needle fasciotomy
Dupuytrens contracture can recur after surgery.
This is usually needed to restore full range of motion and use of the repaired finger(s).
Injecting corticosteroids into nodules during early stages of the condition can sometimes:
- Delay the progressive worsening of the condition
- Ease any tenderness that may be present in the nodules
Another medication that can be injected is called collagenase clostridium histolyticum. This biologic drug breaks down the thickened tissue in the hand.
There are no guidelines to prevent Dupuytrens contracture. Its cause is unknown. However, treatment is made easier and more effective with early detection.
Badalamente MA, Hurst LC, Benhaim P, Cohen BM. Efficacy and safety of collagenase Clostridium Histolyticum in the treatment of proximal interphalangeal joints in Dupuytren contracture: Combined analysis of 4 phase 3 clinical trials. J Hand Surg. 2015;5:975-983.
Degreef I, Tejpar S, Sciot R, De Smet L. High-dosage Tamoxifen as neo adjuvant treatment in minimally invasive surgery for Dupuytren Disease in patients with strong pre disposition toward fibrosis. J Bone Joint Surg Am. 2014;96(8):655-662.
Dupuytren disease. EBSCO DynaMed Plus website. Available at:
http://www.dynamed.com/topics/dmp~AN~T114104/Dupuytren-disease. Updated April 19, 2016. Accessed September 29, 2016.
Lanting R, Broekstra DC, Werker PMN, van den Heuvel ER. A systematic review and meta-analysis on the prevalence of Dupuytren Disease in the general population of Western countries. Plast Reconstr Surg. 2014;133(3):593-603.
Rahr L, et al. Percutaneous needle fasciotomy for primary Dupuytren's contracture.
J Hand Surg Eur Vol. 2011 Sep;36(7):548-52.
Riester S, vanWijnen A, Rizzo M, Kakar S. Pathogenesis and treatment of Dupuytren disease. J Bone Joint Surg Reviews. 2014;2(4):e2.
van Rijssen AL, et al. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy.
Plast Reconstr Surg. 2012 Feb;129(2):469-77.
2/12/2010 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T114104/Dupuytren-disease: FDA approves Xiaflex for debilitating hand condition. US Food and Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm199736.htm. Published February 2, 2010. Accessed September 23, 2014.
Last reviewed September 2015 by Laura Lei-Rivera, DPT
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.